Biotechnology · Berkeley, CA · Founded 2023 · Privately Held (backing)
Operator of a biotechnology platform intended to enable precise genome editing inside the body for disease treatment. Azalea Therapeutics is based in Berkeley, CA and was founded in 2023. It was valued at $153 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $82 million across 1 recorded round; the latest was a $65 million Series A in Oct 2025.
PMV mark · valuation
$153.0M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$82.0M
Last round
Early Stage VC (Series A)
Oct 2025
Team — not yet on record
No current team members for Azalea Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Azalea Therapeutics with a free account
·Watch Azalea Therapeutics: the Monday email on marks, rounds and moves
